S3

Acid Deprotection Procedure
The methyl ester was diluted to a 0.1 M solution in MeOH/CH 2 Cl 2 (1:1), followed by the addition of 8 equivalents of LiOH. The reaction was run at room temperature for 8 h. Upon completion, the reaction mixture was quenched with pH =1 aqueous solution and extracted with CH 2 Cl 2 . The collected organic layer was dried, and concentrated to afford the acid.
Thioamide Synthesis Procedure
The ester (methyl or ethyl) was diluted to a 0.1 M solution of MeOH/NH 4 OH (1:1~1:3). The ester solution was stirred overnight for amide conversion. The solvent was removed in vacuo to afford the amide, which is diluted to a 0.05 M solution. The amide solution was added 0.75 equivalent of Lawesson's reagent for thioamideconversion.
The solvent was then removed and the residue was purified by flash column chromatography to afford the thioamide.
Thiazole Synthesis Procedure
The thioamide was diluted to a 0.05 M solution of 1,2-dimethoxyethane (DME), followed by the addition of 8.0 equivalents of KHCO 3 and 3.0 equivalents of ethyl bromopyruvate. The reaction mixture was stirred for 16 h at room temperature. The solvent was removed and the residue was partitioned between water and chloroform. The collected organic layer was further washed with brine, driedand evaporated. The crude thiazoline residue was redissolved in DME (0.05M) and cooled to 0°C. Pyridine (9.0 equivalents) was slowly added, followed by drop-wise addition of TFAA (4.0 equivalents). After stirring at 0°C for 3 h, the reaction mixture was allowed to warm to room temperature, followed by slowly addition of TEA (2.0 equivalents) and the reaction was stirred for 1 h. The solvent was then evaporated and the residue was dissolved in chloroform, washed with pH =1 solution, saturated aqueous NaHCO 3 solution, dried and concentrated. The residue was purified by flash column chromatography to S4 yield the thiazole. Note: Thiazoletrifluoroacetate may be observed after the reaction is completed. Exposure of the trifluoroacetate to 1.2 equivalents of NaOEt in 0.05 M ethanol solution at 0°C for 1 h gave the desired thiazole ethyl ester.
Hydrogenolysis Procedure
The benzylated serine was dissolved in ethanol (0.1M), followed by addition of catalytic amount of 10% Pd/C. The solution was purged with H 2 and stirred overnight. Upon completion the reaction was filter through celite, rinsed with CH 2 Cl 2 and concentrated to yield desired molecule.
Oxazole Synthesis Procedure
A) Oxazoline formation 1.1 equivalents of DASTwere added drop-wise to the serineinCH 2 Cl 2 (0.1M) at -78 o C under Ar. The reaction mixture was stirred for 1 h, followed by the addition of 2 equivalents of K 2 CO 3 (use pyridine for the synthesis of phenyloxazole) and stirred for an additional 30min. The solution was then allowed to warm to room temperature.
Upon completion, the organic solution was partitioned between saturated aqueous NaHCO 3 and CH 2 Cl 2 . The collected organic layer was dried and concentrated to give the oxazoline, which was subjected to oxidation without further purification.
B) Oxidation
2 equivalents of DBU were added drop-wise to a solution of oxazoline in CH 2 Cl 2 at -46 o C and the solution was stirred for 15 min. 2 equivalents of BrCCl 3 were then added to the reaction mixture, which was allowed to proceed over 12 h. The reaction was worked up using the same method in peptide synthesis procedure and then purified by flash column chromatography to yield the oxazole product. 
Boc-Thr(O t Bu)-Trioxazole-OMe (3)
The intermediateprotected dioxazole-Ser(Bn)-OMewas synthesized using 889 mg of 2and 700 mg of LiOH following "Acid Deprotection Procedure". The obtained free acid was then coupled with 430 mg of NH 2 -Ser(Bn)-OMe using 1.3 mL of DIPEA, and 662 mg of TBTU following "Peptide Synthesis Procedure" The trioxazole3 was synthesized using 1.03 g of protected dioxazole-Ser(Bn)-OMe and 103 mg of 10% Pd/C following "Hydrogenolysis Procedure" to remove benzyl ether then subjected to "OxazoleSynthesis Procedure" using 0.6 mL of DAST and 677 mg of K 2 CO 3 for the first step, 0.5 mL of DBU and 0.3 mL of BrCCl 3 for the second step (colorless oil, 578mg, 70%).
Methods: Cytotoxicity
Cytotoxicity of the compounds against human colon cancer cell line HCT-116 cells was determined using Cell
monosodium salt] reduction assay.
HCT-116 cells (3000 cells/well) in Dulbecco's modified eagle's medium (DMEM; Life Technologies) with 10%
fetal bovine serum were seeded in 96 well tissue culture dish. The cells were allowed to adhere for 24 hoursin CO 2 incubator at 37⁰C before being treated for 72 hours with compounds 1-10 at 40uM concentration. "Media only"
lanes and media with 1% DMSO were used as controls. Post treatment the media was aspirated off and 90µl of fresh serum free media was added to each well. 10µl of room temperature CCK8 reagent (Dojindo Molecular Technologies) was added per well, and the plate was covered in aluminium foil and incubated for 1 hour in CO 2 incubator at 37⁰C. The cell viability was determined colorimetrically using Chromate Microplate Reader (Awareness Technology) at 450nm, and development of an orange-color from reduction of the formazan dye was directly proportional to the number of living cells. Graphs were plotted for log of the concentrations of the compound versus percentage cell survival at 40uM concentration using the GraphPad Prism software.
IC 50 values were determined for compounds that showed 70% or more growth inhibition. The same methodology as mentioned above was applied for treating the cells for 72 hours with compound 6, 8, 9 and 10 at 1µM, 2µM, 5µM, 10µM, 20 µM, 30µM and 40µM concentrations. For each compound, the data was analyzed and IC 50 values were determined by plotting curves for curves for log of the concentrations of the compound versus percentage cell survival using GraphPad Prism software. The experiments were repeated three times with each data point performed in quadruplicate. 
